In this section

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Coates, L. C. et al. (2023) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Rheumatology, 62(1), e1-e3. (doi: 10.1093/rheumatology/keac388) (PMID:35799375)

[img] Text
275131.pdf - Accepted Version
258kB

Abstract

No abstract available.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McInnes, Professor Iain
Authors: Coates, L. C., Garrood, T., Gullick, N., Helliwell, P., Kent, T., Marks, J., Tillett, W., Kaur-Papadakis, D., Tahir, H., van Haaren, S., and McInnes, I.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Research Centre:College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology
Journal Name:Rheumatology
Publisher:Oxford University Press
ISSN:1462-0324
ISSN (Online):1462-0332
Published Online:07 July 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Rheumatology 62(1): e1-e3
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details